These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9312530)

  • 1. [Use of ursodeoxycholic acid in treatment of chronic hepatitis C].
    Warunek W; Zejc-Bajsarowicz M; Librant-Suska M
    Folia Med Cracov; 1996; 37(1-2):97-100. PubMed ID: 9312530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up.
    Angelico M; Gandin C; Pescarmona E; Rapicetta M; Del Vecchio C; Bini A; Spada E; Baroni CD; Capocaccia L
    Am J Gastroenterol; 1995 Feb; 90(2):263-9. PubMed ID: 7847298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ursodeoxycholic acid in the therapy of chronic hepatitis after treatment with interferon].
    Porcaro G; Sannino C; Mastroianni M; Ciavattone A; Bartiromo D; Nascia S
    Minerva Med; 2000; 91(7-8):141-5. PubMed ID: 11155462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha and ribavirin treatment of hepatitis C in children with malignancy in remission.
    Christensson B; Wiebe T; Akesson A; Widell A
    Clin Infect Dis; 2000 Mar; 30(3):585-6. PubMed ID: 10722449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon versus interferon and UDCA combined therapy in chronic hepatitis C.
    Mazur W; Machniak M; Mazurek U; Jurzak M; Wilczok T; Gonciarz Z
    Med Sci Monit; 2001 May; 7 Suppl 1():157-64. PubMed ID: 12211712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C.
    Umemura T; Alter HJ; Tanaka E; Orii K; Yeo AE; Shih JW; Matsumoto A; Yoshizawa K; Kiyosawa K
    Hepatology; 2002 Apr; 35(4):953-9. PubMed ID: 11915044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy for hepatitis C.
    TreatmentUpdate; 1998 Mar; 10(1):2-3. PubMed ID: 11365430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
    Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO
    Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of patients with hepatitis C virus with and without GB virus C/hepatitis G virus co-infection and efficacy of interferon alfa.
    Enomoto M; Nishiguchi S; Fukuda K; Kuroki T; Tanaka M; Otani S; Ogami M; Monna T
    Hepatology; 1998 May; 27(5):1388-93. PubMed ID: 9581696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment with natural interferon (alfaferone) in clinical practice--our experience].
    Dybowska D; Halota W
    Przegl Epidemiol; 2007; 61(1):17-22. PubMed ID: 17702434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic hepatitis treated with alpha-interferon].
    Michael M
    Orv Hetil; 1992 Jul; 133 Suppl 1():63-5. PubMed ID: 1630805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural leukocyte interferon alfa for the treatment of chronic viral hepatitis in heart transplant recipients.
    Fagiuoli S; Pevere S; Minniti F; Livi U; Caforio AL; Naccarato R; Chiaramonte M
    Transplantation; 2003 Apr; 75(7):982-6. PubMed ID: 12698084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of viral hepatitis in children].
    Kekez AJ
    Acta Med Croatica; 2005; 59(5):463-7. PubMed ID: 16381244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
    Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT
    Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Half of the patients respond to interferon treatment. Combination therapy is an alternative in chronic hepatitis C].
    Weiland O; Norkrans G; Frydén A; Braconier JH
    Lakartidningen; 1995 May; 92(18):1920-2. PubMed ID: 7746045
    [No Abstract]   [Full Text] [Related]  

  • 17. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
    Sostegni R; Ghisetti V; Pittaluga F; Marchiaro G; Rocca G; Borghesio E; Rizzetto M; Saracco G
    Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders.
    Brillanti S; Foli M; Di Tomaso M; Gramantieri L; Masci C; Bolondi L
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):130-4. PubMed ID: 10363198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.